Benign neoplasm: Male genital organ, other/unspecified

CD2_BENIGN_MALE_GEN_NOS

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only males

172961

diagram downward connector

Check conditions None

172961

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D29.7&, D29.9&
Hospital discharge: ICD-9 222[8-9]
Hospital discharge: ICD-8 2229
Cause of death: ICD-10 D29.7&, D29.9&
Cause of death: ICD-9 222[8-9]
Cause of death: ICD-8 2229

2 out of 7 registries used, show all original rules.

26

diagram downward connector

Check minimum number of events None

26

diagram downward connector

Include endpoints None

26

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

26

diagram downward connector
CD2_BENIGN_MALE_GEN_NOS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Benign neoplasm: Male genital organ, other/unspecified based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 26 - 26
Unadjusted prevalence (%) 0.01 - 0.02
Mean age at first event (years) 52.08 - 52.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_MALE_GEN_NOS – Benign neoplasm: Male genital organ, other/unspecified
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Benign neoplasm: Male genital organ, other/unspecified

Endpoint not on priority list, no data to show.